COMMUNIQUÉS West-GlobeNewswire

European Patent Office Confirms Patent Protection for SOT201, SOTIO's Clinical-Stage Immunocytokine Showing Promising Anti-Tumor Activity
21/07/2026
PRAGUE and BASEL, Switzerland and BOSTON, July 21, 2026 (GLOBE NEWSWIRE) -- SOTIO Biotech , a clinical-stage biopharmaceutical company owned by PPF Group, today announced that the Boards of Appeal of the European Patent [...]
The National Upper Cervical Chiropractic Association Celebrates 60 Years of Restoring Balance from the Top Down, Creating Optimal Function and Health
21/07/2026
SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE) -- A legacy of longevity. This year, the National Upper Cervical Chiropractic Association (NUCCA) celebrates six decades of advancing education and professional standards [...]
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience
21/07/2026
Aggregate cash dividend of $17.3 million, or approximately $0.40242 per share NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of [...]
Exagen to Announce Second Quarter Financial Results on August 4, 2026
21/07/2026
CARLSBAD, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended June 30, 2026, before the market [...]
Three Peat: USOSM Recognized as One of the Region’s Fastest Growing Companies by Dallas Business Journal
21/07/2026
IRVING, Texas, July 21, 2026 (GLOBE NEWSWIRE) -- For the third year in a row, Irving’s U.S. Oral Surgery Management ( USOSM ) has secured a spot on the Dallas Business Journal’s list of the region’s fastest growing [...]
Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program
21/07/2026
Silo continues to add technology assets as it expands its AI business and further develops its lead PTSD therapeutic candidate AI agent platform prepares for commercial launch while SPC-15 regulatory program advances [...]
SkinHealth Systems to Report Second Quarter 2026 Financial Results on August 6, 2026
21/07/2026
LONG BEACH, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced it will report second quarter [...]
Choosing a Shaker Bottle for Thick Pre-Workout Powders: What Actually Prevents Clumping
21/07/2026
PROMIXX set out to fix what defined the manual shaker category, replacing the wire mixing ball with the Snap-Fit Agitator: a lid-locked mixing grid Cardiff, July 21, 2026 (GLOBE NEWSWIRE) -- The Snap-Fit Agitator is an [...]
Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity
21/07/2026
Jilin, China, July 21, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]
Philips receives FDA 510(k) clearance for next-generation reusable SpO₂ clip sensor
21/07/2026
July 21, 2026 New sensor advances pulse oximetry reliability for diverse patient populations through innovation and rigorous validation. Cambridge, MASS – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health [...]
AssistRx and Medisafe Unite to Power Smarter, More Connected Patient Engagement
21/07/2026
Partnership delivers the real-time status updates and mobile-first engagement today's patients expect from therapy initiation through adherence ORLANDO, Fla., July 21, 2026 (GLOBE NEWSWIRE) -- AssistRx , the advanced [...]
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
21/07/2026
ST. LOUIS, July 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release [...]
SK pharmteco and Genethon Showcase French Manufacturing Strength Behind Pivotal DMD Gene Therapy Program
21/07/2026
Ongoing support for GNT-0004 highlights the capability, readiness, and continued momentum of SK pharmteco’s viral vector operations in France as part of its global network RANCHO CORDOVA, Calif., July 21, 2026 (GLOBE [...]
Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time
21/07/2026
GERMANTOWN, Md., July 21, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today [...]
Revagenix Expands Executive Team, Names Peter Smith, Ph.D., Chief Scientific Officer as Lead Program Enters the Clinic
21/07/2026
Rev-56 scientific leader promoted to CSO to advance Revagenix’s scientific strategy in non-cystic fibrosis bronchiectasis and other serious chronic diseases SAN FRANCISCO, July 21, 2026 (GLOBE NEWSWIRE) -- Revagenix, [...]
OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
21/07/2026
LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
21/07/2026
Lonza grants Engitix target-specific license for GlycoConnect ® , HydraSpace ® and SYNtecan E™ linker-payload technologies for ADC development Collaboration enables innovative treatments by combining Lonza’s validated [...]
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
21/07/2026
Initial customer wins bring VivoSim’s human-relevant liver and GI testing to the world’s second-largest pharmaceutical market SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company [...]
Merakris Therapeutics Awarded NIH Direct-to-Phase II SBIR Grant to Advance MTX-001 for Diabetic Foot Ulcers
21/07/2026
Award supports a two-year project expected to provide up to $2.2 million in non-dilutive funding while expanding Merakris' clinical-stage pipeline into a second major chronic wound indication RESEARCH TRIANGLE PARK, N.C [...]

Pages